The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis

Abstract Background To explore the roles of Annexin A2 (ANXA2) on hepatocyte pyroptosis and hepatic fibrosis in nonalcoholic steatohepatitis (NASH) and underlying molecular mechanism. Methods Bioinformatics analyses were performed on transcriptome data of liver tissues from mice and patients with li...

Full description

Bibliographic Details
Main Authors: Yun Feng, Wenhua Li, Zhuoya Wang, Ruling Zhang, Yan Li, Lijuan Zang, Peiwen Wang, Zhenghong Li, Yuwei Dong
Format: Article
Language:English
Published: BMC 2022-11-01
Series:Journal of Translational Medicine
Subjects:
Online Access:https://doi.org/10.1186/s12967-022-03692-1
_version_ 1798044536774066176
author Yun Feng
Wenhua Li
Zhuoya Wang
Ruling Zhang
Yan Li
Lijuan Zang
Peiwen Wang
Zhenghong Li
Yuwei Dong
author_facet Yun Feng
Wenhua Li
Zhuoya Wang
Ruling Zhang
Yan Li
Lijuan Zang
Peiwen Wang
Zhenghong Li
Yuwei Dong
author_sort Yun Feng
collection DOAJ
description Abstract Background To explore the roles of Annexin A2 (ANXA2) on hepatocyte pyroptosis and hepatic fibrosis in nonalcoholic steatohepatitis (NASH) and underlying molecular mechanism. Methods Bioinformatics analyses were performed on transcriptome data of liver tissues from mice and patients with liver fibrosis for screening the hepatocyte pyroptosis-related differential genes. The in vivo NASH mouse model and in vitro NASH cellular model were established. The expression levels of Anxa2/ANXA2 were quantified. Then, the upstream transcription factor of Anxa2 was screened by ChIP-Seq and experimentally verified. The effects of the p-STAT3/ANXA2 axis on Caspase-1 mediated pyroptosis and fibrosis were explored by in vivo and in vitro experiments. Results Bioinformatics analyses suggested that the expression of Anxa2/ANXA2 was significantly up-regulated in liver tissues of both NASH mice and patients scoring with high pyroptotic activity. Experimental data showed that the ANXA2 expression was positively associated with the development of hepatocyte pyroptosis and fibrosis. As a transcription factor of ANXA2, p-STAT3 can bind to the promoter of Anxa2 and promote its transcription. The inhibition of p-STAT3 can significantly suppress hepatocyte pyroptosis and fibrosis, which was significantly reversed after the over-expression of Anxa2. Caspase-1 was verified as the player of the p-STAT3/ANXA2 axis to promote pyroptosis and fibrosis. By specifically inhibiting Caspase-1, the promotion effect of the p-STAT3/ANXA2 axis on pyroptosis and fibrosis can be significantly weakened. Conclusion The p-STAT3 promoted Anxa2 expression at the transcription level, thus activating the Caspase-1 mediated hepatocyte pyroptosis and fibrosis in NASH.
first_indexed 2024-04-11T23:05:47Z
format Article
id doaj.art-e5ac1992a6d743db91ce1b47697eb489
institution Directory Open Access Journal
issn 1479-5876
language English
last_indexed 2024-04-11T23:05:47Z
publishDate 2022-11-01
publisher BMC
record_format Article
series Journal of Translational Medicine
spelling doaj.art-e5ac1992a6d743db91ce1b47697eb4892022-12-22T03:58:01ZengBMCJournal of Translational Medicine1479-58762022-11-0120111410.1186/s12967-022-03692-1The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitisYun Feng0Wenhua Li1Zhuoya Wang2Ruling Zhang3Yan Li4Lijuan Zang5Peiwen Wang6Zhenghong Li7Yuwei Dong8Department of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Gastroenterology, Jiading Branch of Shanghai General Hospital, Shanghai JiaoTong University School of MedicineDepartment of Endoscopy Center, The First Hospital of Hunan University of Chinese MedicineDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Pathology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Gastroenterology, Xinhua Hospital, Shanghai Jiao Tong University School of MedicineDepartment of Gastroenterology, Shanghai General Hospital, Shanghai Jiao Tong University School of MedicineAbstract Background To explore the roles of Annexin A2 (ANXA2) on hepatocyte pyroptosis and hepatic fibrosis in nonalcoholic steatohepatitis (NASH) and underlying molecular mechanism. Methods Bioinformatics analyses were performed on transcriptome data of liver tissues from mice and patients with liver fibrosis for screening the hepatocyte pyroptosis-related differential genes. The in vivo NASH mouse model and in vitro NASH cellular model were established. The expression levels of Anxa2/ANXA2 were quantified. Then, the upstream transcription factor of Anxa2 was screened by ChIP-Seq and experimentally verified. The effects of the p-STAT3/ANXA2 axis on Caspase-1 mediated pyroptosis and fibrosis were explored by in vivo and in vitro experiments. Results Bioinformatics analyses suggested that the expression of Anxa2/ANXA2 was significantly up-regulated in liver tissues of both NASH mice and patients scoring with high pyroptotic activity. Experimental data showed that the ANXA2 expression was positively associated with the development of hepatocyte pyroptosis and fibrosis. As a transcription factor of ANXA2, p-STAT3 can bind to the promoter of Anxa2 and promote its transcription. The inhibition of p-STAT3 can significantly suppress hepatocyte pyroptosis and fibrosis, which was significantly reversed after the over-expression of Anxa2. Caspase-1 was verified as the player of the p-STAT3/ANXA2 axis to promote pyroptosis and fibrosis. By specifically inhibiting Caspase-1, the promotion effect of the p-STAT3/ANXA2 axis on pyroptosis and fibrosis can be significantly weakened. Conclusion The p-STAT3 promoted Anxa2 expression at the transcription level, thus activating the Caspase-1 mediated hepatocyte pyroptosis and fibrosis in NASH.https://doi.org/10.1186/s12967-022-03692-1p-STAT3ANXA2Caspase-1PyroptosisNASHHepatic fibrosis
spellingShingle Yun Feng
Wenhua Li
Zhuoya Wang
Ruling Zhang
Yan Li
Lijuan Zang
Peiwen Wang
Zhenghong Li
Yuwei Dong
The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
Journal of Translational Medicine
p-STAT3
ANXA2
Caspase-1
Pyroptosis
NASH
Hepatic fibrosis
title The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
title_full The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
title_fullStr The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
title_full_unstemmed The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
title_short The p-STAT3/ANXA2 axis promotes caspase-1-mediated hepatocyte pyroptosis in non-alcoholic steatohepatitis
title_sort p stat3 anxa2 axis promotes caspase 1 mediated hepatocyte pyroptosis in non alcoholic steatohepatitis
topic p-STAT3
ANXA2
Caspase-1
Pyroptosis
NASH
Hepatic fibrosis
url https://doi.org/10.1186/s12967-022-03692-1
work_keys_str_mv AT yunfeng thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT wenhuali thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT zhuoyawang thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT rulingzhang thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT yanli thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT lijuanzang thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT peiwenwang thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT zhenghongli thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT yuweidong thepstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT yunfeng pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT wenhuali pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT zhuoyawang pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT rulingzhang pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT yanli pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT lijuanzang pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT peiwenwang pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT zhenghongli pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis
AT yuweidong pstat3anxa2axispromotescaspase1mediatedhepatocytepyroptosisinnonalcoholicsteatohepatitis